Drug: doxorubicin hydrochloride Quarter: 2016Q3
Total Drug/Injury Combinations: 406 Number of Pages: 21
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| DOXORUBICIN HYDROCHLORIDE. | Skin toxicity | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Soft tissue infection | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Status epilepticus | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Streptococcal infection | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Subarachnoid haemorrhage | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Supraventricular tachycardia | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Syncope | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Systemic candida | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Vascular access complication | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Weight increased | 2 | view events |
| DOXORUBICIN HYDROCHLORIDE. | Wound complication | 2 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Ascites | 1 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Bone marrow failure | 1 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Breast cancer recurrent | 1 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Decreased appetite | 1 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Hepatic failure | 1 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Hepatocellular injury | 1 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Hypoaesthesia oral | 1 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Malignant neoplasm progression | 1 | view events |
| Doxorubicin Hydrochloride (Actavis Inc) | Mucosal inflammation | 1 | view events |
Total Drug/Injury Combinations: 406 Number of Pages: 21
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)